P2RX7 and cancer: Apart from the strategy targeting the P2X7 ion channel, from antibodies and nanobodies to small-molecule drugs, which has been proved to improve the outcomes in models of cancer [20–24], the nature product is also taken into account for the development of potential anti-cancer drug to target purinergic receptors [25, 26].